Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Optimizing the benefits versus harms of prostate-specific antigen screening can be achieved through stratifying screening and biopsy. This clinical consultation guide provides the scientific background and evidence-based recommendations.

Original publication

DOI

10.1016/j.euf.2015.05.001

Type

Journal article

Journal

Eur Urol Focus

Publication Date

09/2015

Volume

1

Pages

149 - 151